REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | Return to index | ||||||||
Order | Gene | Description | ref_hepatocyte | HepG2 | HepG2.C3A | HuH.7 | SNU475 | THLE | liver |
1 | ACTB | Actin, cytoplasmic 1 | [1] | -0.86[2] | -0.97[3] | -0.63[4] | -0.30[5] | -0.68[6] | -0.21[7] |
2 | ACTG1 | Actin, cytoplasmic 2 | [8] | 0.42[9] | -0.33[10] | -0.52[11] | -0.49[12] | -0.09[13] | -0.96[14] |
3 | CLTA | Clathrin light chain A | [15] | -1.34[16] | -0.95[17] | -1.12[18] | -1.76[19] | -1.39[20] | -2.29[21] |
4 | EFNA1 | Ephrin-A1 | [22] | -0.70[23] | 1.36[24] | 0.34[25] | -3.87[26] | -3.96[27] | 1.10[28] |
5 | RAC1 | Ras-related C3 botulinum toxin substrate 1 | [29] | 0.14[30] | 0.38[31] | 0.81[32] | 0.71[33] | 0.70[34] | 0.01[35] |
6 | CLTB | Clathrin light chain B | [36] | -0.03[37] | -1.47[38] | -1.94[39] | -1.95[40] | -1.59[41] | -1.32[42] |
7 | AP2M1 | AP-2 complex subunit mu | [43] | 0.75[44] | 1.13[45] | 0.34[46] | 1.67[47] | 2.19[48] | 0.81[49] |
8 | AP2S1 | AP-2 complex subunit sigma | [50] | -1.09[51] | -0.54[52] | -0.12[53] | -0.05[54] | 0.39[55] | -0.05[56] |
9 | APH1A | Gamma-secretase subunit APH-1A | [57] | 0.46[58] | 1.32[59] | 1.25[60] | 0.43[61] | 0.33[62] | -0.04[63] |
10 | CLTC | Clathrin heavy chain 1 | [64] | 2.15[65] | 2.82[66] | 2.71[67] | 2.38[68] | 2.52[69] | 3.43[70] |
11 | PSENEN | Gamma-secretase subunit PEN-2 | [71] | -1.53[72] | -0.95[73] | -0.76[74] | -1.19[75] | -1.61[76] | -1.09[77] |
12 | YES1 | Tyrosine-protein kinase Yes | [78] | -0.33[79] | 1.73[80] | 1.67[81] | 1.15[82] | 0.61[83] | 1.10[84] |
13 | NCSTN | Nicastrin | [85] | 1.88[86] | 1.61[87] | 1.48[88] | 1.79[89] | 1.67[90] | 1.37[91] |
14 | AP2A1 | AP-2 complex subunit alpha-1 | [92] | 1.74[93] | 1.98[94] | 2.52[95] | 2.10[96] | 2.17[97] | 1.93[98] |
15 | AP2B1 | AP-2 complex subunit beta | [99] | 2.77[100] | 3.07[101] | 4.51[102] | 3.25[103] | 3.11[104] | 1.91[105] |
16 | ADAM10 | Disintegrin and metalloproteinase domain-containing protein 10 | [106] | 1.52[107] | 2.57[108] | 2.31[109] | 1.98[110] | 2.39[111] | 1.77[112] |
17 | VAV2 | Guanine nucleotide exchange factor VAV2 | [113] | 1.83[114] | 2.66[115] | 1.86[116] | 0.16[117] | 0.58[118] | 1.49[119] |
18 | AP2A2 | AP-2 complex subunit alpha-2 | [120] | 1.79[121] | 2.21[122] | 2.05[123] | 1.54[124] | 1.19[125] | 1.65[126] |
19 | EPHA2 | Ephrin type-A receptor 2 | [127] | 2.79[128] | 3.57[129] | 1.11[130] | 1.64[131] | 2.19[132] | 0.20[133] |
20 | EPHB4 | Ephrin type-B receptor 4 | [134] | 2.45[135] | 2.40[136] | 2.38[137] | 0.13[138] | 0.92[139] | 2.66[140] |
21 | PSEN1 | Presenilin-1 | [141] | 1.59[142] | 2.38[143] | 1.66[144] | 1.95[145] | 1.83[146] | 1.97[147] |
22 | LYN | Tyrosine-protein kinase Lyn | [148] | -0.33[149] | 0.07[150] | 0.31[151] | 1.75[152] | 0.51[153] | 0.99[154] |
23 | PSEN2 | Presenilin-2 | [155] | -0.16[156] | -0.44[157] | -4.54[158] | 0.78[159] | -0.59[160] | 0.88[161] |
24 | SRC | Proto-oncogene tyrosine-protein kinase Src | [162] | 3.56[163] | 4.11[164] | 2.83[165] | 3.10[166] | 2.27[167] | 0.13[168] |
25 | EFNA4 | Ephrin-A4 | [169] | 0.78[170] | 0.91[171] | 1.78[172] | -0.02[173] | -0.70[174] | -0.93[175] |
26 | EPHA1 | Ephrin type-A receptor 1 | [176] | 0.71[177] | 2.58[178] | -2.05[179] | -6.25[180] | -6.64[181] | 2.63[182] |
27 | FYN | Tyrosine-protein kinase Fyn | [183] | 1.48[184] | -6.55[185] | 1.73[186] | 2.17[187] | 3.69[188] | 1.95[189] |
28 | EFNA2 | Ephrin-A2 | [190] | 1.77[191] | 2.48[192] | 1.60[193] | -3.06[194] | -4.84[195] | 1.49[196] |
29 | EFNB1 | Ephrin-B1 | [197] | 1.87[198] | 0.44[199] | -6.93[200] | 2.31[201] | 2.38[202] | 1.89[203] |
30 | MMP9 | Matrix metalloproteinase-9 | [204] | -2.19[205] | -2.66[206] | -5.35[207] | -0.73[208] | -3.29[209] | 0.84[210] |
31 | EPHB2 | Ephrin type-B receptor 2 | [211] | -0.30[212] | -4.79[213] | 1.35[214] | 3.07[215] | 3.81[216] | -0.60[217] |
32 | CLTCL1 | Clathrin heavy chain 2 | [218] | 2.61[219] | 2.74[220] | 2.30[221] | 2.60[222] | 2.04[223] | 2.72[224] |
33 | APH1B | Gamma-secretase subunit APH-1B | [225] | 0.30[226] | 1.68[227] | 4.52[228] | 3.79[229] | 2.83[230] | 2.20[231] |
34 | EPHB6 | Ephrin type-B receptor 6 | [232] | -4.57[233] | [234] | -7.22[235] | -1.99[236] | 0.99[237] | 1.77[238] |
35 | TIAM1 | T-lymphoma invasion and metastasis-inducing protein 1 | [239] | -4.17[240] | -0.92[241] | -6.40[242] | -0.66[243] | 1.39[244] | 4.32[245] |
36 | VAV3 | Guanine nucleotide exchange factor VAV3 | [246] | 2.34[247] | 1.20[248] | 3.09[249] | 4.38[250] | -1.60[251] | 2.33[252] |
37 | EFNA3 | Ephrin-A3 | [253] | 2.08[254] | 2.38[255] | 4.20[256] | 1.13[257] | 1.08[258] | 1.48[259] |
38 | EPHB1 | Ephrin type-B receptor 1 | [260] | 1.32[261] | -3.80[262] | -4.95[263] | [264] | -4.92[265] | 2.74[266] |
39 | EPHA10 | Ephrin type-A receptor 10 | [267] | 1.40[268] | 1.33[269] | -0.10[270] | -0.22[271] | -1.22[272] | 0.06[273] |
40 | EFNB2 | Ephrin-B2 | [274] | -0.05[275] | -1.65[276] | 0.99[277] | -0.21[278] | 5.79[279] | 4.80[280] |
41 | DNM1 | Dynamin-1 | [281] | 2.77[282] | 1.52[283] | 2.94[284] | 6.29[285] | 5.78[286] | 2.91[287] |
42 | MMP2 | 72 kDa type IV collagenase | [288] | 3.97[289] | -2.45[290] | -1.45[291] | 8.13[292] | 7.69[293] | 4.91[294] |
43 | EPHB3 | Ephrin type-B receptor 3 | [295] | 1.14[296] | -2.82[297] | 4.18[298] | 4.07[299] | 3.93[300] | 3.98[301] |
44 | EPHA4 | Ephrin type-A receptor 4 | [302] | -4.26[303] | -2.76[304] | -2.38[305] | 3.00[306] | 7.16[307] | 5.73[308] |
45 | EPHA7 | Ephrin type-A receptor 7 | [309] | [310] | [311] | [312] | [313] | 1.66[314] | 1.19[315] |
46 | EFNB3 | Ephrin-B3 | [316] | 3.57[317] | 0.60[318] | 1.92[319] | 4.42[320] | 6.72[321] | 4.64[322] |
47 | EPHA8 | Ephrin type-A receptor 8 | [323] | -0.53[324] | [325] | [326] | -0.28[327] | [328] | [329] |
48 | EFNA5 | Ephrin-A5 | [330] | 1.73[331] | 0.72[332] | 6.55[333] | 8.87[334] | 10.15[335] | 8.43[336] |
49 | EPHA3 | Ephrin type-A receptor 3 | [337] | 2.09[338] | 1.34[339] | 4.25[340] | 1.02[341] | 9.37[342] | 8.89[343] |
50 | EPHA5 | Ephrin type-A receptor 5 | [344] | [345] | [346] | [347] | [348] | [349] | [350] |
51 | EPHA6 | Ephrin type-A receptor 6 | [351] | [352] | [353] | [354] | [355] | [356] | [357] |